SCHEMBL8300158

SCHEMBL8300158

COc1ccc2c(OC)nc(-c3ccccc3)cc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
KDM4E B2RXH2 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
SQOR Q9Y6N5 2/20 0.54
MAPT P10636 2/20 0.53
TSHR P16473 1/20 0.53
ATM Q13315 1/20 0.53
ACACA Q13085 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
VDR P11473 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2B6 P20813 1/20 0.50
AHR P35869 1/20 0.50
NR1I3 Q14994 1/20 0.50
TACR3 P29371 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13409376 0.87 MAPT (0.55) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL13763566 0.85 IDH1 (0.50) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL12463992 0.85 NPC1 (0.48) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL30112701 0.84 KDM4E (0.60) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL6380914 0.84 SQOR (0.58) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL8273166 0.84 NPC1 (0.65) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL8272283 0.83 SQOR (0.60) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL8272309 0.83 NPC1 (0.57) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL508691 0.83 NPC1 (0.57) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL1536512 0.83 NPC1 (0.57) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705146-B2 Hepatitis C inhibitor peptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-27 US disclosed
EP-2033654-A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus Bristol-Myers Squibb Company (US) 2009-03-11 EP disclosed
EP-1629000-B1 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2009-02-18 EP disclosed
WO-2004094452-A2 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-11-04 WO disclosed